BCDA 241115 2.50C (BCDA241115C2500) Stock Options, News & Quotes

$BioCardia (BCDA.US)$
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
BioCardia has completed its Phase III CardiAMP HF trial, a randomized, double-blind, placebo-controlled study evaluating the CardiAMP Cell Therapy System for heart failure treatment. The trial enrolled 125 patients across 18 US hospitals, with 115 patients randomized 3:2 between treatment and control groups. The therapy, which received FDA Breakth...

Boxman

Sep 8 20:00

Here too!

$BioCardia (BCDA.US)$ same unregistered brokerage

104750472

Aug 30 07:06

$BioCardia (BCDA.US)$ 3$ offering yall

Trytosaveabit

Aug 30 07:04

$BioCardia (BCDA.US)$ BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced at-the-Market Under Nasdaq Rules